ERBB2 and breast carcinoma: Do et al.14 speculate that such results support a previous study that suggested integrin α and HER2 are involved in the same signaling pathway, referring to the publication describing a novel mechanism for integrin-mediated Ras activation in breast carcinoma cells36.